These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24113612)

  • 21. Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir.
    Kawai N; Ikematsu H; Iwaki N; Kawashima T; Maeda T; Mitsuoka S; Kondou K; Satoh I; Miyachi K; Yamaga S; Shigematsu T; Hirotsu N; Kashiwagi S
    J Infect; 2007 Sep; 55(3):267-72. PubMed ID: 17604839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influenza antiviral resistance in the Asia-Pacific region during 2011.
    Leang SK; Deng YM; Shaw R; Caldwell N; Iannello P; Komadina N; Buchy P; Chittaganpitch M; Dwyer DE; Fagan P; Gourinat AC; Hammill F; Horwood PF; Huang QS; Ip PK; Jennings L; Kesson A; Kok T; Kool JL; Levy A; Lin C; Lindsay K; Osman O; Papadakis G; Rahnamal F; Rawlinson W; Redden C; Ridgway J; Sam IC; Svobodova S; Tandoc A; Wickramasinghe G; Williamson J; Wilson N; Yusof MA; Kelso A; Barr IG; Hurt AC
    Antiviral Res; 2013 Feb; 97(2):206-10. PubMed ID: 23274624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of timing of oseltamivir chemoprophylaxis in controlling influenza A H3N2 outbreaks in long-term care facilities in Manitoba, Canada, 2014-2015: a retrospective cohort study.
    Singh D; Jiang D; Van Caeseele P; Loeppky C
    Infect Control Hosp Epidemiol; 2018 Aug; 39(8):955-960. PubMed ID: 29893659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the effectiveness of Zanamivir and Oseltamivir against influenza A/H1N1, A/H3N2, and B.
    Kawai N; Ikematsu H; Iwaki N; Maeda T; Kawashima T; Hirotsu N; Kashiwagi S
    Clin Infect Dis; 2009 Apr; 48(7):996-7. PubMed ID: 19260819
    [No Abstract]   [Full Text] [Related]  

  • 25. Neuraminidase inhibitor susceptibility testing of influenza type B viruses in China during 2010 and 2011 identifies viruses with reduced susceptibility to oseltamivir and zanamivir.
    Wang D; Sleeman K; Huang W; Nguyen HT; Levine M; Cheng Y; Li X; Tan M; Xing X; Xu X; Klimov AI; Gubareva LV; Shu Y
    Antiviral Res; 2013 Mar; 97(3):240-4. PubMed ID: 23267831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oseltamivir use in low-birth weight infants during the 2009 nH1N1 influenza a outbreak in the Western Cape, South Africa.
    Holgate SL; Bekker A; Rabie H; Cotton MF
    J Trop Pediatr; 2012 Apr; 58(2):102-6. PubMed ID: 21653546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and tolerability of oseltamivir prophylaxis in hematopoietic stem cell transplant recipients: a retrospective case-control study.
    Vu D; Peck AJ; Nichols WG; Varley C; Englund JA; Corey L; Boeckh M
    Clin Infect Dis; 2007 Jul; 45(2):187-93. PubMed ID: 17578777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety, virology and pharmacokinetics of oseltamivir in infants with laboratory-confirmed influenza: a Phase I/II, prospective, open-label, multicentre clinical trial.
    Rath BA; Brzostek J; Guillén S; Niranjan V; Chappey C; Rayner CR; Clinch B
    Antivir Ther; 2015; 20(8):815-25. PubMed ID: 26015411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.
    Dapat C; Kondo H; Dapat IC; Baranovich T; Suzuki Y; Shobugawa Y; Saito K; Saito R; Suzuki H
    Antiviral Res; 2013 Sep; 99(3):261-9. PubMed ID: 23791870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influenza outbreaks in Singapore: epidemiology, diagnosis, treatment and prevention.
    Tang JW; Loh TP; Tambyah PA; Koay ES
    Expert Rev Anti Infect Ther; 2012 Jul; 10(7):751-60. PubMed ID: 22943399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Virus load kinetics and resistance development during oseltamivir treatment in infants and children infected with Influenza A(H1N1) 2009 and Influenza B viruses.
    Rath B; von Kleist M; Tief F; Karsch K; Tuerk E; Muehlhans S; Louis F; Skopnik H; Schweiger B; Duwe S
    Pediatr Infect Dis J; 2012 Sep; 31(9):899-905. PubMed ID: 22581220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparing clinical characteristics between hospitalized adults with laboratory-confirmed influenza A and B virus infection.
    Su S; Chaves SS; Perez A; D'Mello T; Kirley PD; Yousey-Hindes K; Farley MM; Harris M; Sharangpani R; Lynfield R; Morin C; Hancock EB; Zansky S; Hollick GE; Fowler B; McDonald-Hamm C; Thomas A; Horan V; Lindegren ML; Schaffner W; Price A; Bandyopadhyay A; Fry AM
    Clin Infect Dis; 2014 Jul; 59(2):252-5. PubMed ID: 24748521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in children.
    Sugaya N; Mitamura K; Yamazaki M; Tamura D; Ichikawa M; Kimura K; Kawakami C; Kiso M; Ito M; Hatakeyama S; Kawaoka Y
    Clin Infect Dis; 2007 Jan; 44(2):197-202. PubMed ID: 17173216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral oseltamivir in human experimental influenza B infection.
    Hayden FG; Jennings L; Robson R; Schiff G; Jackson H; Rana B; McClelland G; Ipe D; Roberts N; Ward P
    Antivir Ther; 2000 Sep; 5(3):205-13. PubMed ID: 11075941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review of the clinical effectiveness of the neuraminidase inhibitors against influenza B viruses.
    Farrukee R; Mosse J; Hurt AC
    Expert Rev Anti Infect Ther; 2013 Nov; 11(11):1135-45. PubMed ID: 24093683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 1999-2000 influenza season: Canadian laboratory diagnoses and strain characterization.
    Li Y
    Can Commun Dis Rep; 2000 Nov; 26(22):185-9. PubMed ID: 11131691
    [No Abstract]   [Full Text] [Related]  

  • 37. Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors.
    Escuret V; Frobert E; Bouscambert-Duchamp M; Sabatier M; Grog I; Valette M; Lina B; Morfin F; Ferraris O
    J Clin Virol; 2008 Jan; 41(1):25-8. PubMed ID: 18055253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiviral treatment and prophylaxis of influenza in primary care: German recommendations.
    Wutzler P; Kossow KD; Lode H; Ruf BR; Scholz H; Vogel GE;
    J Clin Virol; 2004 Oct; 31(2):84-91. PubMed ID: 15364262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of oseltamivir in Dutch nursing homes during the 2004-2005 influenza season.
    van der Sande MA; Ruijs WL; Meijer A; Cools HJ; van der Plas SM
    Vaccine; 2006 Nov; 24(44-46):6664-9. PubMed ID: 16797806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparing for pandemic influenza: should hospitals stockpile oseltamivir?
    Cinti S; Chenoweth C; Monto AS
    Infect Control Hosp Epidemiol; 2005 Nov; 26(11):852-4. PubMed ID: 16320980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.